American International Group’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,820
| Closed | -$107K | – | 967 |
|
|
2024
Q1 | $107K | Sell |
1,820
-16
| -0.9% | -$689 | ﹤0.01% | 2478 |
|
|
2023
Q4 | $40.7K | Buy |
1,836
+21
| +1% | +$317 | ﹤0.01% | 2859 |
|
|
2023
Q3 | $39.2K | Buy |
1,815
+65
| +4% | +$2.55K | ﹤0.01% | 2882 |
|
|
2023
Q2 | $118K | Buy |
1,750
+62
| +4% | +$25.6K | ﹤0.01% | 2472 |
|
|
2023
Q1 | $788K | Buy |
1,688
+33
| +2% | +$17.5K | 0.01% | 1343 |
|
|
2022
Q4 | $663K | Sell |
1,655
-6
| -0.4% | -$2.3K | ﹤0.01% | 1435 |
|
|
2022
Q3 | $540K | Buy |
1,661
+24
| +1% | +$7.73K | ﹤0.01% | 1522 |
|
|
2022
Q2 | $432K | Sell |
1,637
-73
| -4% | -$18.7K | ﹤0.01% | 1702 |
|
|
2022
Q1 | $514K | Sell |
1,710
-120
| -7% | -$41.8K | ﹤0.01% | 1705 |
|
|
2021
Q4 | $645K | Sell |
1,830
-55
| -3% | -$17.1K | ﹤0.01% | 1656 |
|
|
2021
Q3 | $482K | Sell |
1,885
-45
| -2% | -$15.9K | ﹤0.01% | 1875 |
|
|
2021
Q2 | $1.28K | Sell |
1,930
-356
| -16% | -$205K | ﹤0.01% | 1373 |
|
|
2021
Q1 | $1.98K | Sell |
2,286
-38
| -2% | -$40.5K | 0.01% | 1115 |
|
|
2020
Q4 | $2.15K | Buy |
2,324
+309
| +15% | +$325K | 0.01% | 1046 |
|
|
2020
Q3 | $2.07M | Sell |
2,015
-17
| -0.8% | -$18.3K | 0.01% | 946 |
|
|
2020
Q2 | $2.06M | Buy |
2,032
+172
| +9% | +$160K | 0.01% | 953 |
|
|
2020
Q1 | $1.62M | Sell |
1,860
-108
| -5% | -$107K | 0.01% | 943 |
|
|
2019
Q4 | $2.11M | Buy |
1,968
+7
| +0.4% | +$7.15K | 0.01% | 974 |
|
|
2019
Q3 | $1.81M | Sell |
1,961
-13
| -0.7% | -$14.3K | 0.01% | 1014 |
|
|
2019
Q2 | $2.23M | Buy |
1,974
+34
| +2% | +$37.2K | 0.01% | 959 |
|
|
2019
Q1 | $2.64M | Sell |
1,940
-63
| -3% | -$85.4K | 0.01% | 916 |
|
|
2018
Q4 | $2.32M | Buy |
2,003
+19
| +1% | +$21.4K | 0.01% | 932 |
|
|
2018
Q3 | $3.01M | Buy |
1,984
+36
| +2% | +$55.4K | 0.01% | 916 |
|
|
2018
Q2 | $3.05M | Buy |
1,948
+166
| +9% | +$216K | 0.01% | 893 |
|
|
2018
Q1 | $2.06M | Sell |
1,782
-96
| -5% | -$126K | 0.01% | 978 |
|
|
2017
Q4 | $2.23M | Buy |
1,878
+104
| +6% | +$130K | 0.01% | 976 |
|
|
2017
Q3 | $2.39M | Buy |
1,774
+299
| +20% | +$315K | 0.01% | 922 |
|
|
2017
Q2 | $1.19M | Buy |
1,475
+185
| +14% | +$129K | ﹤0.01% | 1181 |
|
|
2017
Q1 | $795K | Buy |
1,290
+85
| +7% | +$51.8K | ﹤0.01% | 1315 |
|
|
2016
Q4 | $644K | Sell |
1,205
-3
| -0.2% | -$1.5K | ﹤0.01% | 1484 |
|
|
2016
Q3 | $625K | Buy |
1,208
+2
| +0.2% | +$942 | ﹤0.01% | 1475 |
|
|
2016
Q2 | $495K | Buy |
1,206
+85
| +8% | +$38.9K | ﹤0.01% | 1591 |
|
|
2016
Q1 | $597K | Hold |
1,121
| – | – | ﹤0.01% | 1868 |
|
|
2015
Q4 | $854K | Sell |
1,121
-2
| -0.2% | -$1.33K | ﹤0.01% | 1600 |
|
|
2015
Q3 | $615K | Buy |
1,123
+1
| +0.1% | +$606 | ﹤0.01% | 1834 |
|
|
2015
Q2 | $659K | Buy |
1,122
+888
| +379% | +$516K | ﹤0.01% | 1932 |
|
|
2015
Q1 | $184K | Hold |
234
| – | – | ﹤0.01% | 3031 |
|
|
2014
Q4 | $160K | Buy |
+234
| New | +$151K | ﹤0.01% | 3147 |
|
Other funds holding KYNB
AC
6CM
GCP
American International Group's KYNB Position: Q2 2024 in Review
American International Group sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,820 shares — an estimated $107K sold.
American International Group first reported a position in KYNB in Q4 2014 and held it in 38 quarters. The position peaked at $3.05M in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.
- American International Group reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
- American International Group sold 1,820 Kyntra Bio shares in Q2 2024, an estimated $107K.
- American International Group first reported a position in Kyntra Bio in Q4 2014 and held it in 38 quarters.
- American International Group's Kyntra Bio position peaked at $3.05M in Q2 2018.
- 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.